See more : Juventus Football Club S.p.A. (JVTSF) Income Statement Analysis – Financial Results
Complete financial analysis of Tong Ren Tang Technologies Co. Ltd. (1666.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tong Ren Tang Technologies Co. Ltd., a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
- PROOF Acquisition Corp I WT (PACI-WT) Income Statement Analysis – Financial Results
- Helix BioPharma Corp. (HBPCF) Income Statement Analysis – Financial Results
- Everything Blockchain, Inc. (EBZT) Income Statement Analysis – Financial Results
- Fruta Fruta Inc. (2586.T) Income Statement Analysis – Financial Results
- Orion Metals Limited (ORM.AX) Income Statement Analysis – Financial Results
Tong Ren Tang Technologies Co. Ltd. (1666.HK)
About Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.77B | 5.99B | 5.40B | 4.61B | 4.48B | 5.06B | 5.03B | 4.67B | 4.07B | 3.34B | 2.91B | 2.45B | 1.94B | 1.58B | 1.31B | 1.21B | 1.16B | 1.03B | 1.14B | 983.25M | 864.98M | 662.89M | 497.37M | 338.70M | 308.07M |
| Cost of Revenue | 3.93B | 3.40B | 3.11B | 2.54B | 2.42B | 2.63B | 2.50B | 2.30B | 2.05B | 1.73B | 1.47B | 1.20B | 998.93M | 817.06M | 696.12M | 670.23M | 661.23M | 577.25M | 560.89M | 450.89M | 392.88M | 306.69M | 241.05M | 173.22M | 167.51M |
| Gross Profit | 2.85B | 2.59B | 2.29B | 2.07B | 2.05B | 2.43B | 2.53B | 2.37B | 2.01B | 1.62B | 1.44B | 1.24B | 937.49M | 761.86M | 611.78M | 541.23M | 495.80M | 457.52M | 574.79M | 532.36M | 472.10M | 356.20M | 256.32M | 165.48M | 140.56M |
| Gross Profit Ratio | 42.04% | 43.26% | 42.43% | 44.88% | 45.90% | 47.99% | 50.26% | 50.71% | 49.49% | 48.34% | 49.52% | 50.86% | 48.41% | 48.25% | 46.78% | 44.68% | 42.85% | 44.21% | 50.61% | 54.14% | 54.58% | 53.73% | 51.54% | 48.86% | 45.63% |
| Research & Development | 117.56M | 78.43M | 48.90M | 65.55M | 28.32M | 27.84M | 27.59M | 23.16M | 25.19M | 19.53M | 21.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 633.88M | 483.29M | 477.79M | 402.52M | 397.55M | 364.25M | 364.65M | 199.48M | 204.62M | 264.98M | 244.03M | 197.13M | 184.86M | 146.38M | 126.00M | 116.67M | 125.85M | 104.30M | 97.39M | 103.31M | 129.28M | 120.27M | 100.74M | 62.27M | 54.08M |
| Selling & Marketing | 1.08B | 907.57M | 738.77M | 699.93M | 718.68M | 866.65M | 994.46M | 1.02B | 823.83M | 638.61M | 582.35M | 557.48M | 402.22M | 352.80M | 269.08M | 225.67M | 185.29M | 0.00 | 220.78M | 200.04M | 152.22M | 91.04M | 70.26M | 35.42M | 26.34M |
| SG&A | 1.73B | 1.38B | 1.21B | 1.12B | 1.12B | 1.23B | 1.36B | 1.36B | 1.13B | 903.59M | 826.38M | 754.61M | 587.08M | 499.18M | 395.08M | 342.34M | 311.14M | 104.30M | 318.17M | 303.35M | 281.51M | 211.31M | 171.00M | 97.69M | 80.43M |
| Other Expenses | -117.72M | 0.00 | 0.00 | 0.00 | 0.00 | -884.00K | 120.00K | 0.00 | 0.00 | 0.00 | -10.08M | -9.10M | 0.00 | 0.00 | 0.00 | 0.00 | -425.00K | -2.11M | -103.00K | -344.00K | -421.00K | -477.00K | -173.00K | 0.00 | 0.00 |
| Operating Expenses | 1.73B | 1.37B | 1.21B | 1.13B | 1.14B | 1.24B | 1.36B | 1.36B | 1.13B | 899.61M | 848.95M | 754.61M | 587.08M | 499.18M | 395.08M | 342.34M | 311.14M | 284.18M | 316.35M | 303.35M | 281.51M | 211.31M | 171.00M | 97.69M | 80.43M |
| Cost & Expenses | 5.66B | 4.77B | 4.32B | 3.67B | 3.56B | 3.87B | 3.86B | 3.66B | 3.19B | 2.63B | 2.32B | 1.96B | 1.59B | 1.32B | 1.09B | 1.01B | 972.37M | 861.42M | 877.23M | 754.24M | 674.38M | 518.00M | 412.05M | 270.91M | 247.93M |
| Interest Income | 91.13M | 9.58M | 33.75M | 2.45M | 8.73M | 16.84M | 2.10M | 16.44M | 20.35M | 25.01M | 2.77M | 9.14M | 9.43M | 6.47M | 4.30M | 4.14M | 0.00 | 0.00 | 0.00 | 0.00 | 3.24M | 4.22M | 7.61M | 0.00 | 0.00 |
| Interest Expense | 45.05M | 53.80M | 61.80M | 51.56M | 41.03M | 14.96M | 21.69M | 11.10M | 2.63M | 3.59M | 10.12M | 7.95M | 4.28M | 721.00K | 774.00K | 7.85M | 4.92M | 2.11M | 6.38M | 6.89M | 2.34M | 961.00K | 0.00 | 1.16M | 3.03M |
| Depreciation & Amortization | 186.11M | 261.72M | 249.72M | 270.25M | 160.06M | 88.43M | 85.49M | 79.41M | 71.56M | 57.37M | 44.14M | 43.40M | 39.02M | 42.43M | 47.07M | 0.00 | -425.00K | 0.00 | -103.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 1.30B | 1.39B | 1.26B | 1.14B | 1.04B | 1.28B | 1.25B | 1.08B | 953.38M | 768.98M | 648.98M | 531.74M | 381.33M | 310.35M | 268.04M | 246.02M | 184.24M | 173.35M | 256.62M | 230.04M | 190.59M | 144.89M | 85.33M | 67.79M | 60.14M |
| EBITDA Ratio | 19.23% | 23.24% | 23.25% | 24.76% | 23.31% | 25.34% | 24.85% | 23.22% | 23.44% | 23.02% | 22.30% | 21.76% | 20.51% | 19.66% | 20.49% | 16.42% | 15.92% | 16.75% | 22.75% | 23.29% | 22.03% | 21.86% | 17.16% | 20.01% | 19.52% |
| Operating Income | 1.12B | 1.21B | 1.08B | 943.55M | 938.26M | 1.20B | 1.17B | 1.01B | 881.81M | 711.62M | 604.84M | 480.92M | 332.45M | 262.68M | 216.70M | 198.89M | 184.66M | 173.35M | 258.45M | 229.01M | 190.59M | 144.89M | 85.33M | 67.79M | 60.14M |
| Operating Income Ratio | 16.48% | 20.25% | 19.99% | 20.48% | 20.96% | 23.66% | 23.21% | 21.59% | 21.68% | 21.30% | 20.78% | 19.65% | 17.17% | 16.64% | 16.57% | 16.42% | 15.96% | 16.75% | 22.76% | 23.29% | 22.03% | 21.86% | 17.16% | 20.01% | 19.52% |
| Total Other Income/Expenses | 46.24M | -1.13M | -34.45M | -3.93M | -14.76M | 9.99M | -1.64M | 16.26M | 17.93M | 28.98M | -11.38M | 162.00K | 3.44M | 4.97M | -3.51M | -1.64M | -5.34M | -2.11M | -4.65M | -3.59M | 2.82M | 3.74M | 7.44M | -1.16M | -3.03M |
| Income Before Tax | 1.16B | 1.21B | 1.05B | 939.62M | 923.51M | 1.21B | 1.17B | 1.02B | 899.74M | 740.60M | 595.11M | 481.08M | 335.90M | 267.22M | 220.19M | 197.25M | 179.32M | 171.24M | 251.96M | 225.42M | 193.41M | 148.63M | 92.77M | 66.63M | 57.10M |
| Income Before Tax Ratio | 17.16% | 20.23% | 19.35% | 20.39% | 20.63% | 23.86% | 23.21% | 21.94% | 22.12% | 22.17% | 20.45% | 19.66% | 17.35% | 16.92% | 16.84% | 16.28% | 15.50% | 16.55% | 22.19% | 22.93% | 22.36% | 22.42% | 18.65% | 19.67% | 18.54% |
| Income Tax Expense | 170.14M | 210.37M | 178.21M | 153.11M | 182.12M | 201.22M | 196.33M | 172.52M | 157.16M | 124.24M | 91.95M | 81.55M | 54.44M | 42.13M | 36.27M | 30.51M | 25.66M | 27.78M | 19.47M | 18.16M | 16.49M | -953.00K | -6.91M | 12.25M | 18.84M |
| Net Income | 590.19M | 582.89M | 507.25M | 467.55M | 417.65M | 677.82M | 666.67M | 595.65M | 540.48M | 462.19M | 390.09M | 330.17M | 254.69M | 198.34M | 173.03M | 160.53M | 153.52M | 143.46M | 231.19M | 203.95M | 171.77M | 144.88M | 99.92M | 54.38M | 38.26M |
| Net Income Ratio | 8.71% | 9.73% | 9.39% | 10.15% | 9.33% | 13.40% | 13.27% | 12.77% | 13.29% | 13.83% | 13.40% | 13.49% | 13.15% | 12.56% | 13.23% | 13.25% | 13.27% | 13.86% | 20.36% | 20.74% | 19.86% | 21.86% | 20.09% | 16.06% | 12.42% |
| EPS | 0.46 | 0.46 | 0.40 | 0.37 | 0.33 | 0.53 | 0.52 | 0.47 | 0.42 | 0.36 | 0.32 | 0.28 | 0.22 | 0.17 | 0.15 | 0.14 | 0.14 | 0.14 | 0.21 | 0.19 | 0.16 | 0.14 | 0.09 | 0.07 | 0.06 |
| EPS Diluted | 0.46 | 0.46 | 0.40 | 0.37 | 0.33 | 0.53 | 0.52 | 0.47 | 0.42 | 0.36 | 0.32 | 0.28 | 0.22 | 0.17 | 0.15 | 0.14 | 0.14 | 0.14 | 0.21 | 0.19 | 0.16 | 0.14 | 0.09 | 0.07 | 0.06 |
| Weighted Avg Shares Out | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.21B | 1.18B | 1.18B | 1.18B | 1.18B | 1.18B | 1.14B | 1.10B | 1.10B | 1.10B | 1.10B | 1.10B | 1.10B | 737.65M | 660.00M |
| Weighted Avg Shares Out (Dil) | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.28B | 1.22B | 1.18B | 1.18B | 1.18B | 1.18B | 1.18B | 1.14B | 1.10B | 1.10B | 1.10B | 1.10B | 1.10B | 1.10B | 737.65M | 660.00M |
Source: https://incomestatements.info
Category: Stock Reports